title: Effects of dopamine D1 and D2 agonists and antagonists injected into the nucleus accumbens and globus pallidus on jaw movements of rats.
abstract: The effects of bilateral injections of selective D1 and D2 agonists and antagonists into the anteromedial part of the nucleus accumbens and the globus pallidus on apomorphine-induced jaw movements were studied in ketamine-anaesthetized rats after C1 spinal transection. Both SCH 23390 (0.1 and 1 micrograms) and 1-sulpiride (5 and 25 ng) injected into the nucleus accumbens suppressed the display of jaw movements after apomorphine (0.5 mg/kg i.v.). Injection of 1-sulpiride (5 and 25 ng) into the globus pallidus also blocked the effect of apomorphine, whereas SCH 23390 (1 microgram) injected into the same site was ineffective in this respect. Simultaneous application of the selective D1 and D2 agonists, SKF (1 or 5 micrograms) + quinpirole (10 micrograms), into the nucleus accumbens strongly potentiated the effect induced by local administration of each drug alone; a comparable, but smaller, effect was seen after simultaneous injections of these agents into the globus pallidus. These results show that dopaminergic mechanisms within the nucleus accumbens are involved in apomorphine-induced jaw movements, and that the expression of these movements requires concurrent activation of D1 and D2 receptors.
authors.affiliation: Department of Pharmacology, Nihon University School of Dentistry, Tokyo, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Koshikawa
authors.forename: F
authors.initials: F
authors.lastname: Koshikawa
authors.forename: K
authors.initials: K
authors.lastname: Tomiyama
authors.forename: K
authors.initials: K
authors.lastname: Kikuchi de Beltrán
authors.forename: F
authors.initials: F
authors.lastname: Kamimura
authors.forename: M
authors.initials: M
authors.lastname: Kobayashi
mesh_terms: D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000008:administration & dosage / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects*; D015259:Dopamine Agents / Q000494:pharmacology*; D018492:Dopamine Antagonists; D004873:Ergolines / Q000008:administration & dosage / Q000494:pharmacology; D005917:Globus Pallidus; D007267:Injections; D007568:Jaw; D008297:Male; D009714:Nucleus Accumbens; D019257:Quinpirole; D051381:Rats; D011919:Rats, Inbred Strains; D013469:Sulpiride / Q000008:administration & dosage / Q000494:pharmacology
chemical_list: D015259:Dopamine Agents; D018492:Dopamine Antagonists; D004873:Ergolines; D019257:Quinpirole; D015647:2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; D013469:Sulpiride; D001058:Apomorphine